BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34798981)

  • 21. Prevalence and Progression of Pancreatic Cystic Precursor Lesions Differ Between Groups at High Risk of Developing Pancreatic Cancer.
    Konings IC; Harinck F; Poley JW; Aalfs CM; van Rens A; Krak NC; Wagner A; Nio CY; Sijmons RH; van Dullemen HM; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ;
    Pancreas; 2017 Jan; 46(1):28-34. PubMed ID: 27846136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress report: familial pancreatic cancer.
    Mintziras I; Bartsch DK
    Fam Cancer; 2019 Jul; 18(3):359-362. PubMed ID: 30796632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
    Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
    J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
    Urayama S
    World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pancreatic cancer-screening or surveillance?].
    Sirtl S; Vornhülz M; Hofmann FO; Mayerle J; Beyer G
    Radiologie (Heidelb); 2023 Dec; 63(12):908-915. PubMed ID: 37878016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter study of early pancreatic cancer in Japan.
    Kanno A; Masamune A; Hanada K; Maguchi H; Shimizu Y; Ueki T; Hasebe O; Ohtsuka T; Nakamura M; Takenaka M; Kitano M; Kikuyama M; Gabata T; Yoshida K; Sasaki T; Serikawa M; Furukawa T; Yanagisawa A; Shimosegawa T;
    Pancreatology; 2018 Jan; 18(1):61-67. PubMed ID: 29170051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
    Aslanian HR; Lee JH; Canto MI
    Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in precursor lesions of pancreatic cancer among high-risk groups.
    Potjer TP; Schot I; Langer P; Heverhagen JT; Wasser MN; Slater EP; Klöppel G; Morreau HM; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bargello M; Gress TM; Vasen HF; Bartsch DK; ;
    Clin Cancer Res; 2013 Jan; 19(2):442-9. PubMed ID: 23172884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients.
    Liu K; Joshi V; van Camp L; Yang QW; Baars JE; Strasser SI; McCaughan GW; Majumdar A; Saxena P; Kaffes AJ
    World J Gastroenterol; 2017 Dec; 23(48):8526-8532. PubMed ID: 29358860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refinement of screening for familial pancreatic cancer.
    Bartsch DK; Slater EP; Carrato A; Ibrahim IS; Guillen-Ponce C; Vasen HF; Matthäi E; Earl J; Jendryschek FS; Figiel J; Steinkamp M; Ramaswamy A; Vázquez-Sequeiros E; Muñoz-Beltran M; Montans J; Mocci E; Bonsing BA; Wasser M; Klöppel G; Langer P; Fendrich V; Gress TM
    Gut; 2016 Aug; 65(8):1314-21. PubMed ID: 27222532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?
    Torphy RJ; Schulick RD
    Surg Clin North Am; 2018 Feb; 98(1):25-35. PubMed ID: 29191275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
    Goggins M; Overbeek KA; Brand R; Syngal S; Del Chiaro M; Bartsch DK; Bassi C; Carrato A; Farrell J; Fishman EK; Fockens P; Gress TM; van Hooft JE; Hruban RH; Kastrinos F; Klein A; Lennon AM; Lucas A; Park W; Rustgi A; Simeone D; Stoffel E; Vasen HFA; Cahen DL; Canto MI; Bruno M;
    Gut; 2020 Jan; 69(1):7-17. PubMed ID: 31672839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
    Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
    AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
    [No Abstract]   [Full Text] [Related]  

  • 34. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current Approaches to Pancreatic Cancer Screening.
    Chhoda A; Lu L; Clerkin BM; Risch H; Farrell JJ
    Am J Pathol; 2019 Jan; 189(1):22-35. PubMed ID: 30558719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary vs Familial Pancreatic Cancer: Associated Genetic Syndromes and Clinical Perspective.
    Copur MS; Talmon GA; Wedel W; Hart JD; Merani S; Vargasi LM
    Oncology (Williston Park); 2020 Jun; 34(6):196-201. PubMed ID: 32609864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promising outcomes of screening for pancreatic cancer by genetic testing and endoscopic ultrasound.
    Sud A; Wham D; Catalano M; Guda NM
    Pancreas; 2014 Apr; 43(3):458-61. PubMed ID: 24622079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
    Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
    Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
    Becker AE; Hernandez YG; Frucht H; Lucas AL
    World J Gastroenterol; 2014 Aug; 20(32):11182-98. PubMed ID: 25170203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.
    Del Chiaro M; Verbeke CS; Kartalis N; Pozzi Mucelli R; Gustafsson P; Hansson J; Haas SL; Segersvärd R; Andren-Sandberg Å; Löhr JM
    JAMA Surg; 2015 Jun; 150(6):512-8. PubMed ID: 25853369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.